Literature DB >> 9334988

Oxytocin decreases blood pressure in male but not in female spontaneously hypertensive rats.

M Petersson1, T Lundeberg, K Uvnäs-Moberg.   

Abstract

The aim of the present study was to investigate the effects of repeated injections of oxytocin on blood pressure and heart rate in spontaneously hypertensive rats (SHR). For this purpose subcutaneous (s.c.) injections of oxytocin 1 mg/kg or saline were given for 5 days to male and female SHR. Blood pressure and heart rate were measured daily before, during and after the oxytocin treatment period. In male rats, a significant decrease in blood pressure (systolic; p < 0.01, diastolic; p < 0.05), but no effect on heart rate, was seen the day after the first injection of oxytocin, when compared to saline-treated controls. Blood pressure decreased further in response to each injection and a maximal difference of 21 mmHg (systolic) (p < 0.01), compared to controls, was reached after the last injection. The significant effect was gone 3 days after the last injection, although a tendency to a lower blood pressure in the oxytocin-treated rats persisted. On day 10, the oxytocin-treated SHR males again had a significantly lower systolic blood pressure (p < 0.05). In female SHR, the same treatment with oxytocin affected neither blood pressure nor heart rate. These results show that oxytocin may cause a sustained decrease in blood pressure, without affecting heart rate, in male but not in female SHR.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9334988     DOI: 10.1016/s0165-1838(97)00040-4

Source DB:  PubMed          Journal:  J Auton Nerv Syst        ISSN: 0165-1838


  10 in total

1.  Oxytocin neuron activation prevents hypertension that occurs with chronic intermittent hypoxia/hypercapnia in rats.

Authors:  Heather Jameson; Ryan Bateman; Peter Byrne; Jhansi Dyavanapalli; Xin Wang; Vivek Jain; David Mendelowitz
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-03-25       Impact factor: 4.733

2.  Plasma oxytocin is related to lower cardiovascular and sympathetic reactivity to stress.

Authors:  Karen M Grewen; Kathleen C Light
Journal:  Biol Psychol       Date:  2011-04-29       Impact factor: 3.251

3.  Oxytocin-induced endothelial nitric oxide dependent vasorelaxation and ERK1/2-mediated vasoconstriction in the rat aorta.

Authors:  Qian Xu; Kunping Zhuo; Xiaotian Zhang; Yaoxia Zhang; Jiaojiao Xue; Ming-Sheng Zhou
Journal:  Korean J Physiol Pharmacol       Date:  2022-07-01       Impact factor: 1.718

Review 4.  REVIEW: Oxytocin: Crossing the bridge between basic science and pharmacotherapy.

Authors:  Cedric Viero; Izumi Shibuya; Naoki Kitamura; Alexei Verkhratsky; Hiroaki Fujihara; Akiko Katoh; Yoichi Ueta; Hans H Zingg; Alexandr Chvatal; Eva Sykova; Govindan Dayanithi
Journal:  CNS Neurosci Ther       Date:  2010-07-07       Impact factor: 5.243

Review 5.  Sex-specific differences in hypertension and associated cardiovascular disease.

Authors:  Katrina M Mirabito Colafella; Kate M Denton
Journal:  Nat Rev Nephrol       Date:  2018-01-30       Impact factor: 28.314

6.  Influence of breastfeeding on maternal blood pressure at one month postpartum.

Authors:  Satoko Ebina; Ikuo Kashiwakura
Journal:  Int J Womens Health       Date:  2012-07-11

7.  Vasopressin and oxytocin in control of the cardiovascular system.

Authors:  Nina Japundžić-Žigon
Journal:  Curr Neuropharmacol       Date:  2013-03       Impact factor: 7.363

Review 8.  Complementary Role of Oxytocin and Vasopressin in Cardiovascular Regulation.

Authors:  Ewa Szczepanska-Sadowska; Agnieszka Wsol; Agnieszka Cudnoch-Jedrzejewska; Tymoteusz Żera
Journal:  Int J Mol Sci       Date:  2021-10-24       Impact factor: 5.923

Review 9.  The Paraventricular Nucleus of the Hypothalamus in Control of Blood Pressure and Blood Pressure Variability.

Authors:  Bojana Savić; David Murphy; Nina Japundžić-Žigon
Journal:  Front Physiol       Date:  2022-03-16       Impact factor: 4.566

Review 10.  Vasopressin & Oxytocin in Control of the Cardiovascular System: An Updated Review.

Authors:  Nina Japundžić-Žigon; Maja Lozić; Olivera Šarenac; David Murphy
Journal:  Curr Neuropharmacol       Date:  2020       Impact factor: 7.363

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.